Cardiovascular Diseases

Central Adiposity Improves Cardiovascular Risk Assessment Beyond BMI

Waist circumference (WC) and waist-to-hip ratio (WHR) identified important differences in cardiovascular disease (CVD) risk that were not captured by conventional BMI categories, suggesting that central adiposity can reclassify CVD risk across normal weight, overweight, and obesity and provide additional diagnostic and prognostic information. The US Cross-Cohort Collaboration study included 259,388 participants from 15 cohorts, with a median follow-up of 20.0 years, and evaluated nine outcomes, including myocardial infarction, stroke, heart failure, atrial fibrillation, coronary heart disease, CVD, coronary heart disease mortality, CVD mortality, and all-cause mortality. Among individuals with normal weight, 5% had high WC and 18% had high WHR, while among those with overweight, 39% had high WC and 40% had high WHR, demonstrating substantial discordance between BMI and central adiposity. Among individuals with obesity, 9% had low WC and 45% had low WHR. In people with normal weight or overweight, clinically defined high WC or WHR was associated with a 15%–50% higher risk for most outcomes. Among those with obesity, low WC was generally not associated with significantly different risk compared with normal weight and low WC, except for all-cause mortality, for which the risk was significantly lower. In contrast to men, women with obesity but low WHR still had significantly higher risks for all outcomes compared with women with normal weight and low WHR, although these risks were lower than those among women with obesity and high WHR. Among individuals with obesity, the population attributable risk associated with elevated WC or WHR ranged from 13% to 49%, with the highest estimates observed for elevated WC in heart failure and atrial fibrillation. Overall, WC and WHR can identify misclassification of conventional BMI categories and add diagnostic and prognostic value to CVD risk assessment. Source: https://www.jacc.org/

hyangiu

Recent Posts

Intensive BP Control Reduces Cardiovascular Events After Ischemic Stroke

Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…

20 hours ago

No Significant Reduction in Major Cardiovascular Events with Intensive BP Lowering in T2D

In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…

20 hours ago

Stopping Statins Noninferior to Continuing Them in Older Adults without Known CVD

Among older adults with at least two chronic conditions but no known cardiovascular disease, discontinuing…

22 hours ago

Ziltivekimab and Pelacarsen Show No Clinical Benefit Despite Effective Biomarker Lowering

Two randomized, placebo-controlled trials of targeted therapies—ziltivekimab, a monoclonal antibody neutralizing interleukin-6, and pelacarsen, an…

2 days ago

Cold Drives Heart Failure Hospitalizations in Older US Adults

Among US Medicare beneficiaries, colder ambient temperatures were associated with increased heart failure hospitalizations while…

6 days ago

No Significant Difference Between Initial CTO-PCI and No CTO-PCI Strategies in 10-Year Follow-Up

In the 10-year extended follow-up of the DECISION-CTO trial, an initial strategy of percutaneous coronary…

6 days ago

This website uses cookies.